AB
GILD icon

AT Bancorp’s Gilead Sciences GILD Stock Holding History

AT Bancorp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,323
Closed -$251K – 233
2018
Q1 		$251K Buy
+3,323
New +$264K 0.03% 206
2017
Q4 		– Sell
-4,307
Closed -$349K – 232
2017
Q3 		$349K Sell
4,307
-30,504
-88% -$2.33M 0.04% 187
2017
Q2 		$2.46M Sell
34,811
-13,843
-28% -$921K 0.29% 39
2017
Q1 		$3.31M Buy
48,654
+992
+2% +$69.8K 0.42% 42
2016
Q4 		$3.41M Sell
47,662
-15,690
-25% -$1.17M 0.45% 39
2016
Q3 		$5.01M Sell
63,352
-40,327
-39% -$3.28M 0.69% 27
2016
Q2 		$8.65M Buy
103,679
+20,729
+25% +$1.84M 1.28% 14
2016
Q1 		$7.62M Buy
82,950
+6,232
+8% +$562K 1.15% 18
2015
Q4 		$7.76M Buy
76,718
+21,337
+39% +$2.22M 2.14% 5
2015
Q3 		$5.44M Buy
55,381
+18,971
+52% +$2.11M 1.58% 13
2015
Q2 		$4.26M Sell
36,410
-36,923
-50% -$4.03M 1.1% 26
2015
Q1 		$7.2M Buy
73,333
+11,177
+18% +$1.13M 1.99% 6
2014
Q4 		$5.86M Buy
62,156
+27,364
+79% +$2.83M 1.74% 6
2014
Q3 		$3.7M Sell
34,792
-29,280
-46% -$2.87M 1.08% 29
2014
Q2 		$5.31M Buy
+64,072
New +$4.99M 1.59% 9

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AT Bancorp's GILD Position: Q2 2018 in Review

AT Bancorp sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 3,323 shares — an estimated $251K sold.

AT Bancorp first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $8.65M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • AT Bancorp reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • AT Bancorp sold 3,323 Gilead Sciences shares in Q2 2018, an estimated $251K.
  • AT Bancorp first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
  • AT Bancorp's Gilead Sciences position peaked at $8.65M in Q2 2016.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on AT Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.